Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $12.87B | $119.02 | 0.78% | $7.85M | 224.57x | 0.26 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $32.46B | $242.61 | 6.12% | $1.18B | 39.77x | 3.11 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $6.30B | $80.80 | 1.65% | $119.96M | 75.51x | 0.37 | Bermuda | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | NASDAQ | Biotechnology | $3.33B | $26.46 | -0.30% | $45.39M | 126.00x | 1.22 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $2.25B | $10.05 | 5.35% | $232.99M | 13.96x | 0.68 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $12.21B | $107.62 | 2.60% | $718.44M | 30.23x | 16.96 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $2.23B | $43.57 | -1.56% | $44.05M | 90.77x | 0.36 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $10.16B | $343.34 | 3.16% | $233.29M | 41.52x | 0.10 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $35.49B | $61.73 | 3.42% | $1.18B | 32.84x | 1.03 | United States | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $7.91B | $51.69 | 2.85% | $139.21M | 16.78x | 1.71 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $720.33M | $12.13 | 4.84% | $77.33M | 12.77x | 0.39 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $13.42B | $69.33 | 3.49% | $385.69M | 182.45x | 0.85 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $250.83M | $3.17 | 3.59% | $18.69M | 15.85x | 0.29 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $5.80B | $290.71 | 1.08% | $278.98M | 28.87x | 1.26 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $139.93B | $552.06 | 4.52% | $5.50B | 31.86x | 0.35 | United States | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $16.37B | $252.16 | -0.36% | $1.62B | 16.52x | 1.31 | Ireland | ||
| SPRO | SPERO THERAPEUTICS INC | NASDAQ | Biotechnology | $71.63M | $1.23 | 2.50% | $7.64M | 8.79x | 0.19 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $11.35B | $72.48 | 0.36% | $255.98M | 102.08x | 0.22 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $648.63M | $4.45 | 2.53% | $22.81M | 111.25x | 0.30 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $13.48B | $54.39 | 2.39% | $1.09B | 16.53x | 0.35 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $22.70B | $529.14 | 2.10% | $1.68B | 17.50x | 0.13 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $86.57B | $840.84 | 3.78% | $5.75B | 20.05x | 0.32 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.33B | $39.93 | 2.83% | $280.01M | 12.72x | 0.37 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $26.04B | $128.47 | 4.05% | $2.07B | 15.82x | 0.24 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.